Approaching the axilla in breast cancer: Increasing survival, decreasing morbidity

Acta Oncologica

Volumn 39, Issue 3, 2000, Pages 261-264

  Levitt, S H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE;

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVAL; CONFERENCE PAPER; EARLY DIAGNOSIS; LYMPH NODE METASTASIS; PHYSICIAN ATTITUDE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURY; SYMPOSIUM; TREATMENT PLANNING;

EID: 0033870069     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750012989     Document Type: Conference Paper

References (16)

1. Missed' micrometastases - The extent of the problem
2. Imaging of axillary lymph nodes
3. Can axillary dissection be avoided by improved molecular biological diagnosis?
4. History, present status and future of sentinel node biopsy in breast cancer. The Mary Beves Lecture
5. Technical details of intraoperative lymphatic mapping for early stage melanoma
6. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
7. Sentinel lymph node biopsy in breast cancer. The Aarhus experience
8. Pathologic analysis of sentinel lymph nodes in breast carcinoma
9. Axillary surgery in breast cancer management - Background, incidence and extent of nodal spread, extent of surgery and accurate axillary staging, surgical procedures
10. Omitting axillary surgery for low-risk breast cancer patients - A Swedish prospective cohort study
11. Impact of axillary dissection on staging and regional control in breast tumours less than 10 mm - The DBCG experience
12. Adjuvant radiotherapy in breast cancer - The treatment of lymph node areas
13. Patients with early breast cancer benefit from effective axillary treatment
14. Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone
15. Morbidity related to axillary irradiation in the treatment of breast cancer
16. Risk factors of arm lymphedema in breast cancer patients